Cargando…

ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe

BACKGROUND: The availability and affordability of safe, effective, high-quality, affordable anticancer therapies are a core requirement for effective national cancer control plans. METHOD: Online survey based on a previously validated approach. The aims of the study were to evaluate (i) the availabi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cherny, N I, Sullivan, R, Torode, J, Saar, M, Eniu, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Special Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834140/ https://www.ncbi.nlm.nih.gov/pubmed/28950323 http://dx.doi.org/10.1093/annonc/mdx521

Ejemplares similares

ESMO and WHO: 14 years of working in partnership on cancer control
por: Ullrich, Andreas, et al.
Publicado: (2016)

Availability of assisted peritoneal dialysis in Europe: call for increased and equal access
por: Brown, Edwina A, et al.
Publicado: (2022)

ESMO gave me a chance to help make a difference: a personal reflection on the occasion of receiving the 2015 ESMO Award
por: Cherny, Nathan I
Publicado: (2016)

The hard road to ranking the clinical benefit of antineoplastic agents: ESMO Award 2016 presentation
por: Sobrero, Alberto
Publicado: (2017)

3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
por: Cardoso, F., et al.
Publicado: (2017)

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016
por: Dittrich, Christian, et al.
Publicado: (2016)

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
por: Cardoso, F., et al.
Publicado: (2020)

Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines(☆)
por: Arends, J., et al.
Publicado: (2021)

Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
por: Grassi, L., et al.
Publicado: (2023)

Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules
por: Dafni, Urania, et al.
Publicado: (2017)

Out of hospital cardiac arrest outside home in Sweden, change in characteristics, outcome and availability for public access defibrillation
por: Ringh, Mattias, et al.
Publicado: (2009)

Care of the adult cancer patient at the end of life: ESMO Clinical Practice Guidelines
por: Crawford, G.B., et al.
Publicado: (2021)

ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023
por: Cufer, Tanja, et al.
Publicado: (2023)

Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low‐ and lower‐middle‐income countries
por: Kumar, Somesh, et al.
Publicado: (2020)

Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for adjuvant radiotherapy in breast cancer
por: Sapir, E., et al.
Publicado: (2023)

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
por: Curigliano, G., et al.
Publicado: (2020)

Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care
por: Hui, David, et al.
Publicado: (2018)

The ESMO/ASCO Global Curriculum and the evolution of medical oncology training in Europe
por: Pavlidis, Nicholas, et al.
Publicado: (2016)

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(†)
por: Cardoso, F., et al.
Publicado: (2014)

Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline
por: Stone, P., et al.
Publicado: (2023)

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers
por: Cherny, N I, et al.
Publicado: (2016)

Eliminating Deaths From Cervical Cancer—Report of a Panel at the 7th Annual Symposium on Global Cancer Research, a Satellite Meeting at the Consortium of Universities for Global Health 10th Annual Meeting
por: Binagwaho, Agnes, et al.
Publicado: (2019)

Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group
por: Mandelker, D, et al.
Publicado: (2019)

PB2707: ESMO-MAGNITUDE OF CLINICAL BENEFIT SCALE FOR HAEMATOLOGICAL MALIGNANCIES (ESMO-MCBS:H) VERSION 1.0
por: Kiesewetter, Barbara, et al.
Publicado: (2023)

The CTSA Diversity, Equity, Inclusion, and Accessibility (DEIA) Task Force’s recommendations for the CTSA program consortium
por: Carter-Edwards, Lori, et al.
Publicado: (2022)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer
por: Kanesvaran, R., et al.
Publicado: (2022)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer
por: Im, S.-A., et al.
Publicado: (2023)

Leptomeningeal metastasis from solid tumours: EANO–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
por: Le Rhun, E., et al.
Publicado: (2023)

Facing the Global Challenges of Access to Cancer Medication
por: Jazieh, Abdul Raman, et al.
Publicado: (2018)

Accessing Biospecimens from the H3Africa Consortium
por: Beiswanger, Christine M., et al.
Publicado: (2017)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with renal cell carcinoma
por: Kanesvaran, R., et al.
Publicado: (2021)

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer
por: Yoshino, T., et al.
Publicado: (2023)

Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
por: Eniu, Alexandru, et al.
Publicado: (2019)

Multimorbidity and out-of-pocket expenditure on medicine in Europe: Longitudinal analysis of 13 European countries between 2013 and 2015
por: Palladino, Raffaele, et al.
Publicado: (2023)

Hurdles and delays in access to anti-cancer drugs in Europe
por: Ades, F, et al.
Publicado: (2014)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

Out of pocket payments and access to NCD medication in two regions in Albania
por: Gabrani, Jonila, et al.
Publicado: (2022)

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
por: Gyawali, B., et al.
Publicado: (2021)

EHA evaluation of the ESMO—Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies
por: Kiesewetter, Barbara, et al.
Publicado: (2020)

Out-of-pocket expenditure and mortality in the elderly in Europe: a longitudinal analysis, 2006-20
por: Palladino, R, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_crroqvrrtlbgcsbvfc93eiducu